Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000491956 | SCV000579866 | benign | Hereditary cancer-predisposing syndrome | 2023-05-25 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000491956 | SCV000681529 | likely benign | Hereditary cancer-predisposing syndrome | 2023-06-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002523433 | SCV000768341 | likely benign | Familial adenomatous polyposis 1 | 2024-11-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001775829 | SCV002013852 | uncertain significance | not provided | 2020-03-02 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Center for Genomic Medicine, |
RCV002465690 | SCV002760348 | uncertain significance | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Foundation for Research in Genetics and Endocrinology, |
RCV002523433 | SCV003915758 | uncertain significance | Familial adenomatous polyposis 1 | 2023-04-07 | criteria provided, single submitter | clinical testing | A heterozygous missense substitution (p.Ser843Gly) lies in exon 16 of the APC gene and alters a highly conserved residue in the protein. In silico prediction of the variant are damaging by LRT, Mutation Taster and SIFT. In summary, the variant meets our criteria to be classified as a variant of uncertain significance. |
Baylor Genetics | RCV002523433 | SCV004207317 | uncertain significance | Familial adenomatous polyposis 1 | 2022-12-19 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004003444 | SCV004839690 | likely benign | Classic or attenuated familial adenomatous polyposis | 2023-11-20 | criteria provided, single submitter | clinical testing | |
3DMed Clinical Laboratory Inc | RCV000677765 | SCV000803921 | uncertain significance | Hepatocellular carcinoma | 2017-09-23 | no assertion criteria provided | clinical testing |